Linda Feldbrügge1,2, Alan C Moss1, Eric U Yee3, Eva Csizmadia1, Shuji Mitsuhashi1, Maria Serena Longhi1, Bynvant Sandhu1, Holger Stephan4, Yan Wu1, Adam S Cheifetz1, Christa E Müller5, Jean Sévigny6,7, Simon C Robson1, Z Gordon Jiang1. 1. Division of Gastroenterology and Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. 2. Department of Surgery, Charité Universitätsmedizin, Berlin, Germany. 3. Department of Pathology, OU Medical Center, Oklahoma City, USA. 4. Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany. 5. Pharmaceutical Institute, University of Bonn, Bonn, Germany. 6. Département de Microbiologie-infectiologie et d'Immunologie, Université Laval, Québec, QC, Canada. 7. Centre de Recherche du CHU de Québec-Université Laval, Québec, QC, Canada.
Abstract
OBJECTIVE: Recent studies have suggested that the enteric nervous system can modulate gut immunity. Ecto-nucleoside triphosphate diphosphohydrolases [E-NTPDases] regulate purinergic signalling by sequential phosphohydrolysis of pro-inflammatory extracellular adenosine 5'-triphosphate [ATP]. Herein, we test the hypothesis that E-NTPDases modulate gut inflammation via neuro-immune crosstalk. DESIGN: We determined expression patterns of NTPDase2 and NTPDase3 in murine and human colon. Experimental colitis was induced by dextran sodium sulphate [DSS] in genetically engineered mice deficient in NTPDase2 or NTPDase3. We compared plasma adenosine diphosphatase [ADPase] activity from Crohn's patients and healthy controls, and linked the enzyme activity to Crohn's disease activity. RESULTS: NTPDase2 and -3 were chiefly expressed in cells of the enteric nervous system in both murine and human colon. When compared with wild type, DSS-induced colitis was exacerbated in Entpd2, and to a lesser extent, Entpd3 null mice as measured by disease activity score and histology, and marked anaemia was seen in both. Colonic macrophages isolated from Entpd2 null mice displayed a pro-inflammatory phenotype compared with wild type. In human plasma, Crohn's patients had decreases in ADPase activity when compared with healthy controls. The drop in ADPase activity was likely associated with changes in NTPDase2 and -3, as suggested by inhibitor studies, and were correlated with Crohn's disease activity. CONCLUSIONS: NTPDase2 and -3 are ecto-enzymes expressed in the enteric nervous system. Both enzymes confer protection against gut inflammation in experimental colitis and exhibit alterations in Crohn's disease. These observations suggest that purinergic signalling modulated by E-NTPDases governs neuro-immune interactions that are relevant in Crohn's disease.
OBJECTIVE: Recent studies have suggested that the enteric nervous system can modulate gut immunity. Ecto-nucleoside triphosphate diphosphohydrolases [E-NTPDases] regulate purinergic signalling by sequential phosphohydrolysis of pro-inflammatory extracellular adenosine 5'-triphosphate [ATP]. Herein, we test the hypothesis that E-NTPDases modulate gut inflammation via neuro-immune crosstalk. DESIGN: We determined expression patterns of NTPDase2 and NTPDase3 in murine and human colon. Experimental colitis was induced by dextran sodium sulphate [DSS] in genetically engineered mice deficient in NTPDase2 or NTPDase3. We compared plasma adenosine diphosphatase [ADPase] activity from Crohn's patients and healthy controls, and linked the enzyme activity to Crohn's disease activity. RESULTS: NTPDase2 and -3 were chiefly expressed in cells of the enteric nervous system in both murine and human colon. When compared with wild type, DSS-induced colitis was exacerbated in Entpd2, and to a lesser extent, Entpd3 null mice as measured by disease activity score and histology, and marked anaemia was seen in both. Colonic macrophages isolated from Entpd2 null mice displayed a pro-inflammatory phenotype compared with wild type. In human plasma, Crohn's patients had decreases in ADPase activity when compared with healthy controls. The drop in ADPase activity was likely associated with changes in NTPDase2 and -3, as suggested by inhibitor studies, and were correlated with Crohn's disease activity. CONCLUSIONS: NTPDase2 and -3 are ecto-enzymes expressed in the enteric nervous system. Both enzymes confer protection against gut inflammation in experimental colitis and exhibit alterations in Crohn's disease. These observations suggest that purinergic signalling modulated by E-NTPDases governs neuro-immune interactions that are relevant in Crohn's disease.
Authors: Shuji Mitsuhashi; Linda Feldbrügge; Eva Csizmadia; Masato Mitsuhashi; Simon C Robson; Alan C Moss Journal: Inflamm Bowel Dis Date: 2016-07 Impact factor: 5.325
Authors: Makoto Naganuma; Elizabeth B Wiznerowicz; Courtney M Lappas; Joel Linden; Mark T Worthington; Peter B Ernst Journal: J Immunol Date: 2006-09-01 Impact factor: 5.422
Authors: Beat M Künzli; Pascal O Berberat; Karen Dwyer; Silvia Deaglio; Eva Csizmadia; Peter Cowan; Anthony d'Apice; Gregory Moore; Keiichi Enjyoji; Helmut Friess; Simon C Robson Journal: Dig Dis Sci Date: 2010-10-09 Impact factor: 3.199
Authors: Martina Di Giovangiulio; Simon Verheijden; Goele Bosmans; Nathalie Stakenborg; Guy E Boeckxstaens; Gianluca Matteoli Journal: Front Immunol Date: 2015-11-20 Impact factor: 7.561
Authors: Giovanni Pallio; Alessandra Bitto; Gabriele Pizzino; Federica Galfo; Natasha Irrera; Francesco Squadrito; Giovanni Squadrito; Socrate Pallio; Giuseppe P Anastasi; Giuseppina Cutroneo; Antonio Macrì; Domenica Altavilla Journal: Front Pharmacol Date: 2016-08-23 Impact factor: 5.810
Authors: Vladimir Grubišić; Alberto L Perez-Medina; David E Fried; Jean Sévigny; Simon C Robson; James J Galligan; Brian D Gulbransen Journal: Am J Physiol Gastrointest Liver Physiol Date: 2019-06-12 Impact factor: 4.052
Authors: Bynvant Sandhu; Maria C Perez-Matos; Stephanie Tran; Garima Singhal; Ismail Syed; Linda Feldbrügge; Shuji Mitsuhashi; Julie Pelletier; Jinhe Huang; Yusuf Yalcin; Eva Csizmadia; Shilpa Tiwari-Heckler; Keiichi Enjyoji; Jean Sévigny; Eleftheria Maratos-Flier; Simon C Robson; Z Gordon Jiang Journal: Metabolism Date: 2021-02-23 Impact factor: 8.694
Authors: Linda Feldbrügge; Katrin Splith; Ines Kämmerer; Sandra Richter; Anna Riddermann; Santiago Andres Ortiz Galindo; Felix Krenzien; Tobias Müller; Eva Csizmadia; Johann Pratschke; Simon C Robson; Moritz Schmelzle Journal: Int J Mol Sci Date: 2020-08-20 Impact factor: 5.923
Authors: Vladimir Grubišić; Vedrana Bali; David E Fried; Holger K Eltzschig; Simon C Robson; Michelle S Mazei-Robison; Brian D Gulbransen Journal: Mucosal Immunol Date: 2022-07-22 Impact factor: 8.701
Authors: Siobhan Crittenden; Ashleigh Cheyne; Alexander Adams; Thorsten Forster; Calum T Robb; Jennifer Felton; Gwo-Tzer Ho; Dominik Ruckerl; Adriano G Rossi; Stephen M Anderton; Peter Ghazal; Jack Satsangi; Sarah E Howie; Chengcan Yao Journal: Immunol Cell Biol Date: 2018-07-10 Impact factor: 5.126